Trade Paradigm Biopharmaceuticals Limited - PARau CFD

Trading Conditions

• Type: CFD
• Spread: 0.007
• Long position overnight funding adjustment: -0.02208%
• Short position overnight funding adjustment: 0.00016%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: AUD
• Min traded quantity: 100
• Margin: 5.00%
• Stock exchange: Australia
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 0.249
• Open: 0.249
• 1-Year Change: -35.16%
• Day's Range: 0.249 - 0.254

What is Paradigm Biopharmaceuticals Limited (PARau)?

Paradigm Biopharmaceuticals Limited is an Australian biotechnology company focused on the development and commercialization of novel therapeutics for the treatment of chronic inflammatory and degenerative diseases. The company’s research primarily targets conditions such as osteoarthritis and other musculoskeletal disorders. Paradigm Biopharmaceuticals engages in the discovery and development of peptide-based drugs, leveraging its proprietary technology platform to advance its pipeline. The company collaborates with various research institutions and clinical partners to conduct preclinical and clinical studies aimed at validating the efficacy and safety of its drug candidates. Paradigm Biopharmaceuticals operates within the broader biopharmaceutical industry, which involves the application of biological and medical sciences to develop therapies that address unmet medical needs. Its activities encompass drug discovery, clinical development, regulatory affairs, and intellectual property management. The company’s strategic focus includes advancing its lead compounds through regulatory approval processes to ultimately provide new treatment options for patients with chronic inflammatory conditions.

Paradigm Biopharmaceuticals Limited Stock Price Today: Live Overview

The price today is shaped by intraday market activity, with Paradigm Biopharmaceuticals Limited at A$0.256. The price variation today ranges from A$0.249 to A$0.254, with a daily change of 0%.

FAQ: Paradigm Biopharmaceuticals Limited (PARau)

What is the current price of PARau stock?

The current price stands at A$0.256.

Does PARau pay dividends?

Paradigm Biopharmaceuticals Limited pays dividends via cash distributions (if applicable).

Does PARau have a formal corporate presence or regional headquarters in the UAE?

The company operates through partners and distributors in the UAE and does not have an official regional office or subsidiary.

What is PARau best known for?

Paradigm Biopharmaceuticals Limited is most famous for its development of novel treatments for chronic inflammatory diseases.

What assets are typically shown together with PARau?

Commonly shown alongside PARau: Strategic Education Inc, Restore PLC, Sony Corporation